淋巴结转移的模式和腺癌的治疗结果
Wei Wang1,2, Shu Yi1, Pu-Gen An1,2
1Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
BMC oral health
|February 22, 2025
概括
这项研究分析了原发性乳头癌 (PPC),以了解宫淋巴结的传播和生存结果. 高度瘤和高级T-阶段与隐性转移有关,这表明部剖析对特定患者有好处.
科学领域:
- 在瘤学瘤学.
- 头部和部手术 头部和部手术
- 癌症研究 癌症研究
背景情况:
- 初级癌 (PPC) 在理解宫淋巴结转移方面存在独特的挑战.
- 描述传播模式和预后因素对于有效的治疗策略至关重要.
研究的目的:
- 为了研究宫淋巴结转移在原发性乳头癌的模式.
- 评估影响外科手术和辅助治疗后生存的预后因素.
- 评估治疗方式对无病生存期 (DFS) 和整体生存期 (OS) 的影响.
主要方法:
- 对136名被诊断患有原发性癌的患者进行了回顾性分析.
- 利用考克斯危险模型进行生存分析和逻辑回归,用于与淋巴结转移相关的相关因素.
- 评估结果包括无病生存率 (DFS) 和整体生存率 (OS).
主要成果:
- 在PPC患者中检测到60.0% (cT1-2) 和84.1% (cT3-4) 的淋巴结转移;隐性转移率在cN0.0中为55.2%.
- 第二级 (93.2%) 和第一级 (49.3%) 是最常见的转移部位.
- 组织学类型,等级,pT阶段和AJCC阶段显著预测了淋巴结转移. 五年的OS为49.3%,DFS为34.8%.
结论:
- 高度组织学和高级T分类与PPC中隐性淋巴结转移相关.
- 手术后的放射治疗 (RT) 或放射化疗 (RCT) 显著改善了生存结果.
- 在cN0患者中,高度或高级T期PPC患者的部剖析可增强DFS,并建议进行.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


